Personalised nutrition intervention for breast cancer survivors based on individual molecular analyses (nutrigenetics, lipidomics and microbiomics)

Precision nutrition for breast cancer survivors based on molecular tools: nutrigenetics, lipidomics and microbiomics

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN13901439

Enrollment

Registered

2021-10-19

Start date

2021-09-01

Completion date

Unknown

Last updated

2023-11-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nutritional and metabolic status, and well being of breast cancer survivors Nutritional, Metabolic, Endocrine

Interventions

Prospective randomized controlled clinical trial with nutritional intervention for a year with a total of 50 breast cancer survivors. Participants will be randomly divided into two equal size groups:

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: Breast cancer survivors (at least 6 months after treatment), with hormonal treatment

Exclusion criteria

Exclusion criteria: 1. Metastasis 2. Severe malnutrition 3. Allergy to fish 4. Any difficulty to take supplements 5. Without gallbladder

Design outcomes

Primary

Measure	Time frame
1. Metabolic status will be measured as the rebalance of the lipidomic analyses and other biochemical parameters (standard biochemistry parameters: blood cholesterol, TG.) together with anthropometric parameters at 6 and 12 months. 2. Well-being will be measured using validated questionaries (EORTC QLQ-30 or similar) at 6 and 12 months. 3. Improvements of dietary habits will be assessed by validated food frequency questionnaire (FFQ from predimed) at 6 and 12 months.	—

Measure

Time frame

1. Metabolic status will be measured as the rebalance of the lipidomic analyses and other biochemical parameters (standard biochemistry parameters: blood cholesterol, TG.) together with anthropometric parameters at 6 and 12 months. 2. Well-being will be measured using validated questionaries (EORTC QLQ-30 or similar) at 6 and 12 months. 3. Improvements of dietary habits will be assessed by validated food frequency questionnaire (FFQ from predimed) at 6 and 12 months.

—

Secondary

Measure	Time frame
Cancer recurrence: relapses will be measured at 12 months using patient records	—

Countries

Spain

Contacts

Public ContactMercedes Caro

mcaro@azti.es+34 667100352

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026